PProgram in detamil

Day 1. Sep.2(Thu) Day 2. Sep.3(Fri) Day 3. Sep.4(Sat)

Sep.2(Thu) Pre-Congress Symposium 1 (KOR) 15:30-17:00 National Obesity Strategy in The Era of COVID-19 Room 1

Kyoung-Kon Kim (External Affairs and Policy)

15:30-15:40 ( )

Session 1.

15:40-16:05 ( )

16:05-16:20 ( ) ( )

Session 2.

16:20-16:45 , ( )

16:45-17:00 ( ) ( )

Sep.2(Thu) Satellite Symposium 1 (Daiichi-Sankyo) 19:00-20:00 Room 1

Sung Rae Kim (The Catholic University of Korea, Korea)

Prevention of CVD in Hypertension with Diabetes Mellitus Youngwoo Jang (Gachon University, Korea)

Sep.2(Thu) Satellite Symposium 2 (Boehringer Ingelheim) 19:00-20:00 Room 2

Seon Mee Kim (, Korea)

How to Approach Patients with Type 2 Diabetes in Perspective of Cardio-Renal Metabolism and Current Treatment Algorithm Chantal Mathieu (Medicine at the Katholieke Universiteit and Chair of Endocrinology at the University Hospital Gasthuisberg Leuven, Belgium) PProgram in detamil

Day 1. Sep.2(Thu) Day 2. Sep.3(Fri) Day 3. Sep.4(Sat)

Sep.3(Fri) Breakfast Symposium 1 (LG Chem) 07:30-08:00 Room 1

Sang Yeoup Lee (Pusan National University, Korea)

The Renoprotective Effect and Safety of Gemigliptin for Type 2 Diabetes Jun Hwa Hong (Eulji University, Korea)

Sep.3(Fri) Breakfast Symposium 2 (SANOFI) 07:30-08:00 Room 2

Sung Soo Kim (Chungnam National University, Korea)

The Korean Titration Study: Simple & Easy Titration Method for Glargine 300 Young Min Cho (Seoul National University, Korea)

Sep.3(Fri) Keynote Lecture 1 08:15-08:55 Room 1 + Room 2 + Room 3

Chang Beom Lee (Chairman of Korean Society for the Study of Obesity, Korea)

Background and Results of STEP 6 Study on Efficacy and Safety of Semaglutide in Japanese and Korean Takashi Kadowaki (Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Japan)

Sep.3(Fri) Symposium 1 09:00-10:30 Obesity and Cardiovascular Disease Room 1

Young Seol Kim (, Korea) Kee-Ho Song (, Korea)

09:00-09:30 Kartell of Death: Visceral Obesity and Cardiovascular Disease Carl (Chip) J. Lavie (Louisiana State University, USA)

09:30-10:00 Cardiovascular Risk: Variability Matters Kyung Mook Choi (Korea University, Korea)

10:00-10:30 CV Risk in Metabolically Healthy Obesity Changhee Jung (University of , Korea)

Sep.3(Fri) Symposium 2 09:00-10:30 Gut Microbiome, Obesity and Metabolic Disorders Room 2

GwangPyo Ko (Seoul National University, Korea) Soon Jib Yoo (The Catholic University of Korea, Korea)

09:00-09:30 Roles of Gut Microbes In The Pathogenesis and Development of Obesity, NAFLD, and Diabetes: A Systems Perspective Hao Wu (Fudan University, China)

09:30-10:00 Global and Temporal State of Human Microbiome in Health and Disease Sunjae Lee (Gwangju Institute of Science and Technology, Korea)

10:00-10:30 Multiomics Approach for Targeting Novel Microbiome Therapeutics Against Metabolic Diseases GwangPyo Ko (Seoul National University, Korea)

Sep.3(Fri) Symposium 3 09:00-10:30 Novel Mechanistic Insights of Appetite and Weight Control Room 3

Ki Woo Kim (, Korea) Min-Seon Kim (University of Ulsan, Korea)

09:00-09:30 The Role of The Hypothalamic Cereblon (CRBN) in The Control of Feeding Behavior and Body Weight Jaemin Lee (DGIST, Korea)

09:30-10:00 Long-Term Increase of AgRP Neuron Activity Causes Body Weight Gain without Affecting Food Intake Jong-Woo Sohn (KAIST, Korea)

10:00-10:30 Algorithms for Appetite Sco Sternson (UCSD, USA)

Sep.3(Fri) Symposium 4 09:00-10:30 Socioeconomic Inequalities in Obesity Epidemiology Room 4

Kyoung-Kon Kim (Gachon University, Korea) Yang Im Hur (, Korea)

09:00-09:30 Socioeconomic Differentials in Obesity in Australia Mark Harris (Centre for Primary Health Care and Equity, UNSW, Australia)

09:30-10:00 Socioeconomic and Gender Inequalities in Obesity in Taiwan Wen-Harn Pan (Institute of Biomedical Sciences Academia Sinica Taipei, Taiwan)

10:00-10:30 Trends in Socioeconomic Inequalities in Major Risk Factors for Cardiovascular Disease in Korea Sin Gon Kim (Korea University, Korea)

Sep.3(Fri) Sponsored Session 1 (MSD) 09:00-10:30 Strategies to Provide Better Life for Type 2 Diabetes Patients Room 5

Sang-Ah Chang (The Catholic University of Korea)

09:00-09:35 Keep Your Confidence on Type 2 DM in Broad Range of Patients So Hun Kim (Inha University, Korea)

09:35-10:10 The Latest Evidence of SGLT2 Inhibitors for Patients with Type 2 Diabetes Suk Chon (Kyung Hee University, Korea)

10:10-10:30 Discussion

Sep.3(Fri) Opening Address 10:40-10:45 Room 1 + Room 2 + Room 3

Jae-Heon Kang (President of Korean Society for the Study of Obesity, Korea)

Sep.3(Fri) Plenary Lecture 1 Room 1 + Room 2 + Room 3 10:45-11:25

Young Kil Choi (Kyung Hee University, Korea)

Implication of Obesity in Cardiometabolic Risk Robert H. Eckel (University of Cololado Anschutz Medical Center, USA)

Sep.3(Fri) Oral Presentation 1 Room 4 11:30-12:30

Jun Sung Moon (, Korea) Ji Won Yoon (Seoul National University, Korea)

Jin-Wook Kim (Uijeongbu Eulji Medical Center, Korea) Sarah Woo (Hallym University, Korea) Akinkunmi Okekunle (Seoul National University, Korea) Soo Lim (Seoul National University Bundang Hospital, Korea) Gyu Bae Lee (Korea University College of Medicine, Korea) Premkumar Natraj (Jeju National University, Korea)

Sep.3(Fri) Oral Presentation 2 Room 5 11:30-12:30

Young-Jun Rhie (Korea University, Korea) Jang Won Son (The Catholic University of Korea, Korea)

Janice Ee Fang Tay (UCSI University, Malaysia) Kyung Jae Lee (Hallym University College of Medicine, Korea) Shindy Soedono (Soonchunhyang University, Korea) Ji-Hyeon Park (Seoul National University Hospital, Korea) Minji Sohn (Seoul National University Bundang Hospital, Korea) Yong Hyun Park (The catholic University of Korea, Korea)

Sep.3(Fri) Luncheon Symposium 1 (Alvogen) Room 1 12:40-13:40

Soon Jib Yoo (The Catholic University of Korea, Korea)

Long-Term Efficacy & Safety on Combination Phentermine Plus Topiramate ER : Where Do We Stand? Tae Jung Oh (Seoul National University, Korea)

Sep.3(Fri) Luncheon Symposium 2 (MSD) Room 2 12:40-13:40

Jeong-Taek Woo (Kyung Hee University, Korea)

Individualized T2DM Treatment Focus on Recent Treatment Option Jae Hyuk Lee (, Korea)

Sep.3(Fri) Luncheon Symposium 3 (DAEWOONG) Room 3 12:40-13:40

Jae-Heon Kang (President of Korean Society for the Study of Obesity, Korea)

Glycemic Variability: Glycemic Control for Reversing Diabesity Ji-Won Lee (Yonsei University, Korea)

Sep.3(Fri) Luncheon Symposium 4 (Chong Kun Dang Pharm) Room 4 12:40-13:40

Soon Jib Yoo (Catholic University of Korea, Korea)

Long-Term Efficacy & Safety on Combination Phentermine Plus Topiramate ER : Where Do We Stand? Tae Jung Oh (Seoul National University, Korea)

Sep.3(Fri) Symposium 5 13:40-15:10 Obesity Drug Room 1

Sang Woo Oh (, Korea) Kyung Hee Park (Hallym University, Korea)

13:40-14:10 Role of Amylin Analogues in Obesity Management Carel le Roux (University College Dublin, Ireland)

14:10-14:40 Obesity Control with SGLT2i and GLP1RA Combination Therapy Jun Hwa Hong (Eulji University, Korea)

14:40-15:10 Patient-Centered Anti-Obesity Medication Sang Yeoup Lee (Pusan National University, Korea)

Sep.3(Fri) Symposium 6 13:40-15:10 New Paradigm for Clinical Nutrition on Obesity (Untact) Room 2

Cho-il Kim (Seoul National University, Korea) Kyeong Sook Yim (Suwon University, Korea)

13:40-14:10 Get Cooking: Tele-Nutrition for Managing Obesity and Metabolic Diseases Rani Polak (Institute of Lifestyle Medicine, USA)

14:10-14:40 Online eLearning Nutrition Education and Obesity Prevention for Low-Income Adults: Experiences from the University of Georgia Supplemental Nutrition Assistance Program Education (UGA SNAP-Ed) Jung Sun Lee (University of Georgia, USA)

14:40-15:10 A New Paradigm for Clinical Nutrition Services in The Era of The Fourth Industrial Revolution Jung-Sook Seo (Yeungnam University, Korea)

Sep.3(Fri) Symposium 7 13:40-15:10 COVID-19 and Obesity Room 3

Kwan Woo Lee (, Korea) You-Cheol Hwang (Kyung Hee University, Korea)

13:40-14:10 Dissecting The Risk Factor of Severe COVID-19 Patients with Obesity and Metabolic Disorders Jae-Han Jeon (Kyungpook National University, Korea)

14:10-14:40 Management of Obesity-Lessons Learnt from COVID-19 Alice Pik Shan Kong (The Chinese University of Hong Kong, China)

14:40-15:10 COVID-19 Vaccination and Obesity Won Suk Choi (Korea University, Korea)

Sep.3(Fri) Symposium 8 13:40-15:10 Bariatric Surgery Room 4

Yong Jin Kim (H Plus Yangji Hospital, Korea) Youn-baik Choi (University of Ulsan, Korea)

13:40-14:10 Endoscopic Bariatric Procedures Silvana Perre (Research Institute against Digestive Cancer IRCAD, France)

14:10-14:40 Prediction Model for Chronological Weight Loss after Bariatric Surgery in Korean Patients Ji Yeon Park (Kyungpook National University, Korea)

14:40-15:10 Diabetes Remission after Sleeve Plus Procedure in Korean Patients Yong Jin Kim (H Plus Yangji Hospital, Korea)

Sep.3(Fri) Sponsored Session 2 (Alvogen) 13:40-15:10 Is Obesity A Comorbid Disease? Room 5

Kiyoung Lee (Gachon University, Korea)

13:40-14:10 The Efficacy & Safety of Combination Phentermine Plus Topiramate ER for Obese Patients with Hypertension and Hyperlipidemia Hyuktae Kwon (Seoul National University, Korea)

14:10-14:40 The Efficacy and Safety of Combination Phentermine Plus Topiramate ER for Obese Patients with Type 2 Diabetes Mellitus Wonjin Kim (CHA University, Korea)

14:40-15:10 The Benefits of Prescribing Combination Phentermine Plus Topiramate ER for Obese Patient from The Clinician’s Perspective Sun Hyung Kim (G7 Clinic, Korea)

Sep.3(Fri) Keynote Lecture 2 15:30-16:10 Room 1 + Room 2 + Room 3

Moon-Kyu Lee (Eulji University, Korea)

Role of GLP1 Analogues and Other Gut Hormones in Obesity Management John Wilding (University of Liverpool, UK)

Sep.3(Fri) Symposium 9 Room 1 16:10-17:40 Novel Insights into Obesity Comorbidities Ⅰ

Seung-Hwan Lee (The Catholic University of Korea, Korea) In-Kyu Lee (Kyungpook National University, Korea)

16:10-16:40 Role of NAFLD in Metabolically Healthy and Unhealthy Obesity Norbert Stefan (University Hospital of Tübingen, Germany)

16:40-17:10 Current Status and Future Trends in NASH Therapeutics Yong-ho Lee (Yonsei University, Korea)

17:10-17:40 How Does Obesity Affect Cancer Incidence and Mortality? Hae-Jin Ko (Kyungpook National University, Korea)

Sep.3(Fri) Symposium 10 16:10-17:40 Elderly Obesity - Sarcopenic Obesity Room 2

Cheol-Young Park (, Korea) Hye Soon Park (University of Ulsan, Korea)

16:10-16:40 Importance of Body Composition in Obesity Management Steven Heymsfield (Pennington Biomedical Research Center Louisiana State University System, USA)

16:40-17:10 Muscle Matters in Older Men and Fat Matters in Older Women Chang Won Won (Kyung Hee Univrsity, Korea)

17:10-17:40 Sarcopenia in Asia Liang-Kung Chen (Taipei Municipal Gan-Dau Hospital, Taiwan / National Yang Ming Chiao Tung University, Taiwan)

Sep.3(Fri) Symposium 11 16:10-17:40 COVID-19 and Impact on Childhood Obesity and Comorbidities Room 3

Dong Hwan Lee (, Korea) Kye Shik Shim (Kyung Hee University, Korea)

16:10-16:40 Collateral Health Impact of Containing COVID-19 in Children Young June Choe (Korea University, Korea)

16:40-17:10 Impact of COVID-19 on Pediatric Obesity and Comorbidities Moonbae Ahn (The Catholic University of Korea, Korea)

17:10-17:40 COVID-19 and Its Impact on Childhood Obesity Pik To Cheung (Virtus Medical Group, China)

Sep.3(Fri) Symposium 12 (JOMES Session) 16:10-17:40 Enlightening The Future of Obesity through Publication Room 4

Soo Lim (Seoul National University, Korea) Kyung Mook Choi (Korea University, Korea)

16:10-16:30 Obesity, The Official Journal of The Obesity Society Donna H. Ryan (Pennington Biomedical Research Center, USA)

16:30-16:50 To Publish in The International Journal of Obesity Nikhil V. Dhurandhar (Texas Tech University, USA)

16:50-17:10 The development and Trajectory of “Obesity Research and Clinical Practice” Gary Wi ert (University of Adelaide, Australia)

17:10-17:25 Past, Present and Future of JOMES Eun-Jung Rhee (Sungkyunkwan University, Korea)

17:25-17:40 Panel Discussion Chang Hee Jung (University of Ulsan, Korea) Bo Kyung Koo (Seoul National University, Korea)

Sep.3(Fri) Sponsored Session 3 (Novo Nordisk) 16:10-17:40 Innovation in Obesity Management by Connecting GLP-1RA Research and Clinical Evidences Room 5

Chong Hwa Kim (Sejong General Hospital, Korea)

16:10-16:40 Evidence Based Choice for Effective and Safe Obesity Therapeutics Jamy Ard (Wake Forest School of Medicine, USA)

16:40-17:10 Connecting Research to Clinical Implication Success with GLP-1RA Lo e Bjerre Knudsen (Novo Nordisk, Global Drug Discovery, Denmark)

17:10-17:40 Role of GLP-1RA on Visceral Obesity and Cardiometabolic Risk Factors Jee-Hyun Kang (Konyang University, Korea) PProgram in detamil

Day 1. Sep.2(Thu) Day 2. Sep.3(Fri) Day 3. Sep.4(Sat)

Sep.4(Sat) Breakfast Symposium 3 (DALIM BIOTECH) 07:30-08:00 Room 1

Kyu Rae Lee (Gachon University, Korea)

Optimal Dose of Vitamin B12 in T2DM, GI Disorders, Neurologic Disorders and CVD Why Do We Need 1,000 Vit B12 Formulation? Sun Woo Kim (Dalim Biotech, Korea)

Sep.4(Sat) Breakfast Symposium 4 (Kwangdong) 07:30-08:00 Room 2

Hyuk-Sang Kwon (The Catholic University of Korea, Korea)

Obesity, a Disease that Requires Long-term Treatment (Long-Term Efficacy and Safety of CONTRAVE) Byung Wook Yoo (Soonchunhyang University, Korea)

Sep.4(Sat) Breakfast Symposium 5 (AJU PHARM) 07:30-08:00 Room 3

Jeong Hyun Park (Inje University, Korea)

What Do Physicians Consider to Treat ASCVD High-Risk Patient with Dyslipidemia? Tae-Jin Song (Ewha Womans University, Korea)

Sep.4(Sat) Keynote Lecture 3 08:15-08:55 Room 1 + Room 2 + Room 3

Jae-Heon Kang (President of Korean Society for the Study of Obesity, Korea)

Precision Lifestyle Medicine to Manage Cardiometabolic Risk in Obesity Jean-Pierre Després (Université Laval, Canada)

Sep.4(Sat) Symposium 13 Room 1 09:00-10:30 Novel Insights into Obesity Comorbidities Ⅱ

Soo Lim (Seoul National University, Korea) JungHwan Kim (Eulji University, Korea)

09:00-09:30 Obesity, Diet and The Risk of Cognitive Decline and Dementia Deborah R. Gustafson (State University of New York Downstate Health Sciences University, USA)

09:30-10:00 Obesity, Metabolic Health and Chronic Kidney Disease Yun Kyung Cho (Hallym University, Korea)

10:00-10:30 Obesity and Diabetes in Patients with Gastric Cancer: Legitimacy of Onco-Metabolic Surgery Yeongkeun Kwon (Korea University, Korea)

Sep.4(Sat) Symposium 14 09:00-10:30 Circadian Influences (Rhythm) of Diet on Weight Control Room 2

In Joo Kim (Pusan National University, Korea) Jung Eun Lee (Seoul National University, Korea)

09:00-09:30 Circadian Influences of Diet on Weight and Metabolic Health Leonie Kaye Heilbronn (The University of Adelaide, Australia)

09:30-10:00 Circadian Rhythm, Diet and Obesity Mirkka Maukonen (Finnish Institute for Health and Welfare, Finland)

10:00-10:30 The Effect of Time-Restricted Eating on Weight Loss and Metabolic Health YoonJu Song (The Catholic University of Korea, Korea)

Sep.4(Sat) Symposium 15 09:00-10:30 Cutting-edge Basic Research and Methodology in Obesity Biology Room 3

Taesik Park (Gachon University, Korea) Yun-Hee Lee (Seoul National University, Korea)

09:00-09:30 Single Cell Functional Genomics Reveals Plasticity of Subcutaneous White Adipose Tissue (WAT) during Early Postnatal Development James Granneman (Wayne State University School of Medicine, USA)

09:30-10:00 Tracing Metabolic Flux In Vivo in Obesity Research Il-Young Kim (Gachon University, Korea)

10:00-10:30 Regulatory Roles of Hippo STK Kinases in Adipose Tissue Remodeling Yun-Hee Lee (Seoul National University, Korea)

Sep.4(Sat) Symposium 16 09:00-10:30 New Approaches to Obesity Based on Psychiatric Views Room 4

So Hee Lee (National Medical Center, Korea) Tae Kyung Lee (Chuncheon National Hospital, Korea)

09:00-09:30 The Role of Highly Processed Food Addiction in Obesity Ashley Gearhardt (University of Michigan, USA)

09:30-10:00 Can Food Addiction Be a Formal Diagnostic Disorder? Marc N. Potenza (Yale University, USA)

10:00-10:30 Understanding of Obesity in Perspective of Eating Disorders Youl-Ri Kim (Inje University, Korea)

Sep.4(Sat) Sponsored Session 4 (YUHAN) 09:00-10:30 Empagliflozin from RCT to Real World_How to Interpret Room 5

Tae Sun Park (Jeonbuk National University, Korea)

09:00-09:30 How to Interpret The Empagliflozin from RTC to Real World Chong Hwa Kim (Sejong General Hospital, Korea)

09:30-10:00 Beyond Diabetes: The Role of Empagliflozin in Heart Failure Jong-Chan Youn (The Catholic University of Korea, Korea)

10:00-10:30 Trajenta®: Simplifying The Management of T2DM - A Focus on CARMELINA Study Jung Hwan Park (Hanyang University, Korea)

Sep.4(Sat) Symposium 17 10:40-12:10 Digital Therapeutics Room 1

Dae Jung Kim (Ajou University, Korea) Sang Youl Rhee (Kyung Hee University, Korea)

10:40-11:10 Modeling Obesity-Related Behavior in Real Time Donna Spruijt-Metz (University of Southern California, USA)

11:10-11:40 Digital Therapeutics for Obesity Management Hyuktae Kwon (Seoul National University, Korea)

11:40-12:10 Application of Digital Phenotypes in Real-World Clinical Fields Chul-Hyun Cho (Chungnam National University, Korea)

Sep.4(Sat) Symposium 18 10:40-12:10 The Effect of Exercise on Obesity and Related Metabolic Dysfunction Room 2

Wook Song (Seoul National University, Korea) Jong-Hee Kim (Hanyang University, Korea)

10:40-11:10 Benefits of Moderate Exercise Regimen that Ameliorates Cognitive Decline and Hippocampal Lactate Transporter in Type 2 Diabetic Rats Hideaki Soya (University of Tsukuba, Japan)

11:10-11:40 Obesity Paradox: The Fatness or Fitness? Yoonsuk Jekal (Jeju National University, Korea)

11:40-12:10 Effects of Vitamin D and Physical Exercise on High Fat Diet-Induced Obese Mice Jinkyung Cho (Korea Institute of Sport Science, Korea)

Sep.4(Sat) Symposium 19 10:40-12:10 Cutting-edge in Pediatric Type 2 Diabetes Room 3

Kee-Hyoung Lee (Korea University, Korea) Sochung Chung (Konkuk University, Korea)

10:40-11:10 Current Guidelines of Care for Children with Type 2 Diabetes Mellitus Hae Woon Jung (Kyung Hee University, Korea)

11:10-11:40 Predicting The Transition from Metabolically Healthy Obesity to Metabolic Disease in Youth with Obesity Jennifer Kuk (York University, Canada)

11:40-12:10 What Is The Optimal Exercise Strategy for The Prevention of Type 2 Diabetes in Youth? SoJung Lee (Kyung Hee University, Korea)

Sep.4(Sat) Symposium 20 10:40-12:10 Obesity-Related Health Outcomes: A Lifecycle Perspective Room 4

Won-Young Lee (Sungkyunkwan University, Korea) Jangwon Son (The Catholic University of Korea, Korea)

10:40-11:10 Differences in The Effects of Obesity on Diabetes Risk According to Age Groups Eun-Jung Rhee (Sungkyunkwan University, Korea)

11:10-11:40 Obesity and Cardiovascular Outcomes in Different Age Groups Ga Eun Nam (Korea University, Korea)

11:40-12:10 Life Expectancy in Different Age Groups Ye Seul Yang (The Catholic University of Korea, Korea)

Sep.4(Sat) Sponsored Session 5 (Hanmi Pharm.Co.,Ltd.) 10:40-12:10 Optimal Treatment Strategy for Dyslipidemia Room 5

Sung Rae Kim (The Catholic University of Korea, Korea)

10:40-11:10 Why Should We Consider Rosuvastatin+Ezetimibe Combination? Jun Hwa Hong (Eulji University, Korea)

11:10-11:40 Beyond LDL-C in Managing Cardiovascular Risk Jae Hyuk Lee (Hanyang University, Korea)

11:40-12:10 Discussion Yang-Hyun Kim (Korea University, Korea) Seung-Hwan Lee (The Catholic University of Korea, Korea)

Sep.4(Sat) Luncheon Symposium 5 (Handok) 12:20-13:20 Room 1

Kyung-Soo Kim (The Catholic University of Korea, Korea)

Exploring The Extended Benefits of Ipragliflozin Focusing on NAFLD Sang Youl Rhee (Kyung Hee University, Korea)

Sep.4(Sat) Luncheon Symposium 6 (DONG-A ST) 12:20-13:20 Room 2

Young-Sung Suh (Keimyung University, Korea)

Cardiovascular Safety of Evogliptin in Patients with Type 2 Diabetes : A Nationwide Cohort Study Sung Hoon Yu (Hanyang University, Korea)

Sep.4(Sat) Luncheon Symposium 7 (AstraZeneca) 12:20-13:20 Room 3

Hyun Ho Shin (Asan Chungmu Hospital, Korea)

Connecting The Dots from Diabetes to Heart Failure & Chronic Kidney Disease with Dapagliflozin Changhee Jung (University of Ulsan, Korea)

Sep.4(Sat) Luncheon Symposium 8 (HK inno.N Corp.) 12:20-13:20 Room 4

Yang-Hyun Kim (Korea University, Korea)

New Paradigm of Glycemic Variability: EVERGREEN Study Hyuk-Sang Kwon (The Catholic University of Korea, Korea)

Sep.4(Sat) Oral Presentation 3 13:20-14:20 Room 4

Won Jun Kim (University of Ulsan, Korea) Byoungduck Han (Korea University, Korea)

Chulhyun Kim (Soonchunhyang University, Korea) Abdelaziz Ghanemi (Faculty of Medicine, Laval University, Canada) Sungwoo Choi (Korean Advanced Institute of Science and Technology, Korea) Pardeep Kumar (Shri Maha Maya Vaishnav Devi Mandir Research Institute, India) Byungyong Ahn (University of Ulsan, Korea) SRUTHI C R ( Academy of Scientific and Innovative Research (AcSIR), Kerala, India)

Sep.4(Sat) Oral Presentation 4 13:20-14:20 Room 5

Jung Hwan Park (Hanyang University, Korea) Minsu Park (Seoul ND Clinic, Korea)

Kyung-Won Hong (Theragen Bio Co., Ltd., Korea) Rifaldy Fajar (Yogyakarta State University, Indonesia) Young Hee Lee (Seoul National University College of Medicine, Korea) Takashi Kadowaki (Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Japan) Yun Kyung Cho (Hallym University Sacred Heart Hospital, Korea) Kun-Young Park (Korea Advanced Institute of Science and Technology, Korea)

Sep.4(Sat) Best Article in JOMES 14:30-15:30 Room 1

Won-Young Lee (Sungkyunkwan University, Korea) Eun-Jung Rhee (Sungkyunkwan University, Korea)

14:30-14:45 Anti-Obesity Effects of Artemisia annua Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of Uncoupling Protein 1 Seon-Hee Kim (Sungkyun Biotech Co.,LTD., Korea)

14:45-15:00 Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease Dong-Mee Lim (Konyang University, Korea)

15:00-15:15 Obesity Fact Sheet in Korea, 2020: Prevalence of Obesity by Obesity Class from 2009 to 2018 Ga Eun Nam (Korea University, Korea)

15:15-15:30 Award

Sep.4(Sat) Hot Topic in Obesity 2021(1) 14:30-15:30 Room 2

Il-Young Kim (Gachon University, Korea)

14:30-15:00 Measurement of Intracellular Protein Dynamics, Functional Muscle Mass and Virus-Specific T-Cell Longevity Minimally-Invasively in Humans: “Virtual Biopsy” in Pathophysiology and Drug Development Marc Hellerstein (University of California, USA)

15:00-15:30 Role of Extracellular Vesicles in Disease Progression and Prevention Mark A Febbraio (Monash University, Australia)

Sep.4(Sat) Hot Topic in Obesity 2021(2) 14:30-15:30 Room 3

Kyong Soo Park (Seoul National University, Korea)

14:30-15:00 Strategy for The Remission of Type 2 Diabetes Hyuk-Sang Kwon (The Catholic University of Korea, Korea)

15:00-15:30 Genetics and Epigenetics in Obesity and Related Metabolic Disorders Soo Heon Kwak (Seoul National University, Korea)

Sep.4(Sat) Cooking Class for Healthy Life 14:30-15:30 Room 4

K-food and Home Meal Replacement for Preventing Obesity Jeeyeon Kim (The Catholic University of Korea, Korea) Hyewon Lee (Food & Culture Korea, Korea)

Sep.4(Sat) Sponsored Session 6 (CELLTRION PHARM) 14:30-15:30 The Metabolic Syndrome & Diabesity Associated Factors, How Should It Be Managed? Room 5

Eun Gyoung Hong (Hallym University, Korea)

14:30-14:55 How to Treat Hypertension in The Metabolic Syndrome Dae Jung Kim (Ajou University, Korea)

14:55-15:20 Cardiometabolic Benefit of Antidiabetic Agent; Pioglitazone Su Jin Jeong (Sejong General Hospital, Korea)

15:20-15:30 Discussion

Sep.4(Sat) Keynote Lecture 4 15:40-16:20 Room 1 + Room 2 + Room 3

Hyung Joon Yoo (CM Hospital, Korea)

The Use of Systems Biology in Treatment of Liver Diseases Adil Mardinoglu (King’s College London, UK / KTH-Royal Institute of Technology, Sweden)

Sep.4(Sat) Plenary Lecture 2 16:30-17:10 Room 1 + Room 2 + Room 3

Kwang-Won Kim (Gachon University, Korea)

Role of Incretin-Based Therapy in Obesity Management Michael A. Nauck (Ruhr-University, Germany)

Sep.4(Sat) Closing & Award Ceremony 17:10-17:30 Room 1 + Room 2 + Room 3

Chang Beom Lee (Chairman of Korean Society for the Study of Obesity, Korea)